BRIEF published on 11/26/2025 at 00:51, 10 months 4 days ago CureVac annonce les résultats de son assemblée générale extraordinaire Assemblée Générale Extraordinaire BioNTech Approbation Des Actionnaires CureVac Fusion Légale
BRIEF published on 11/26/2025 at 00:51, 10 months 4 days ago CureVac Announces Results of Extraordinary General Meeting BioNTech Extraordinary General Meeting CureVac Shareholders Approval Legal Merger
PRESS RELEASE published on 11/26/2025 at 00:46, 10 months 4 days ago CureVac Announces Voting Results of Extraordinary General Meeting CureVac announces approval of BioNTech's exchange offer for outstanding shares at Extraordinary General Meeting with over 99.16% approval rate BioNTech MRNA Technology Exchange Offer CureVac EGM Voting Results
BRIEF published on 11/24/2025 at 13:15, 10 months 6 days ago CureVac publie ses résultats financiers du troisième trimestre et des neuf premiers mois de 2025 Performance Financière CureVac Technologie De L'ARNm Résultats Du Troisième Trimestre 2025 Fusion BioNTech
BRIEF published on 11/24/2025 at 13:15, 10 months 6 days ago CureVac Reports Q3 and Nine-Month Financial Results for 2025 Financial Performance MRNA Technology CureVac Q3 2025 Results BioNTech Merger
PRESS RELEASE published on 11/24/2025 at 13:10, 10 months 6 days ago CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates CureVac announces financial results for Q3 and first nine months of 2025, BioNTech transaction progresses, EMA clearance received for cancer therapy CVHNLC sqNSCLC Financial Results Cancer Therapy CureVac BioNTech Transaction EMA Clearance
BRIEF published on 08/15/2025 at 13:32, 1 year 1 month ago CureVac Reports Q2 and H1 2025 Financial Results; Announces Key Developments Financial Results MRNA Technology CureVac Patent Resolution BioNTech Acquisition
BRIEF published on 08/15/2025 at 13:32, 1 year 1 month ago CureVac publie ses résultats financiers du deuxième trimestre et du premier semestre 2025 et annonce des développements clés Résultats Financiers CureVac Technologie De L'ARNm Résolution De Brevet Acquisition De BioNTech
PRESS RELEASE published on 08/15/2025 at 13:27, 1 year 1 month ago CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac announces Q2 2025 financial results, business updates & agreement with BioNTech for transformative mRNA treatments. Strong cash position Financial Results BioNTech CureVac MRNA Q2 2025
BRIEF published on 08/08/2025 at 02:20, 1 year 1 month ago CureVac Settles Patent Dispute with Pfizer/BioNTech MRNA Technology CureVac Pfizer/BioNTech Patent Resolution Vaccine Royalties
Published on 09/30/2026 at 13:30, 4 minutes ago Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program
Published on 09/30/2026 at 13:00, 34 minutes ago Grid Metals Announces Maiden Cesium Resource at Falcon West; Establishes Lucy South Cesium Deposit as the World's Second Largest Cesium Resource in Active Development
Published on 09/30/2026 at 11:00, 2 hours 34 minutes ago High Tide Resources Stakes More Ground at Labrador West Iron Project as Drilling Concludes for 2026
Published on 09/30/2026 at 08:00, 5 hours 34 minutes ago Alpha Growth Management Opens Rep Office in Japan
Published on 09/30/2026 at 02:05, 11 hours 29 minutes ago Annual Report for the Year Ended 30 June 2026
Published on 09/30/2026 at 13:02, 32 minutes ago Correction of a release from 28.09.2026 10:18 GMT/BST - POS-Transaction in Own Shares
Published on 09/30/2026 at 13:00, 34 minutes ago The Kayon Gangga Resort Opens in East Bali, Unveiling a New Luxury Sanctuary Rooted in Culture, Cuisine and Wellness
Published on 09/30/2026 at 13:00, 34 minutes ago EnviTec Biogas performs as planned in the first half of 2026 and accelerates its transition from electricity to biomethane production
Published on 09/30/2026 at 12:59, 35 minutes ago EQS-Adhoc: 11880 Solutions AG raises EBITDA forecast for 2026
Published on 09/30/2026 at 12:14, 1 hour 20 minutes ago Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/30/2026 at 12:00, 1 hour 34 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 09/30/2026 at 12:00, 1 hour 34 minutes ago Capital increase through exercise of subscription rights
Published on 09/30/2026 at 08:45, 4 hours 49 minutes ago Air Liquide invests over 170 million euros to support a semiconductor leader expanding manufacturing capabilities in Japan
Published on 09/30/2026 at 08:45, 4 hours 49 minutes ago Air Liquide investit plus de 170 millions d’euros pour accompagner un leader des semi-conducteurs dans le développement de ses capacités de production au Japon
